Levocarnitine

Levocarnitine

SCHEMBL2447788

C[N+](C)(C)CC(O)CC(=O)O.Cl.NCCCC[C@H](N)C(=O)O.NCCCC[C@H](N)C(=O)O.[O-2].[O-2].[Zn+2].[Zn+2].[Zn+2]

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Levocarnitine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ GSR P00390 1/20 0.56
▸ MAPT P10636 1/20 0.51
▸ SLC22A16 Q86VW1 1/20 0.40
▸ ARG2 P78540 4/20 0.40
▸ NOS2 P35228 4/20 0.39
▸ NOS1 P29475 3/20 0.39
▸ BLM P54132 1/20 0.39
▸ GPR84 Q9NQS5 4/20 0.37
▸ ARG1 P05089 3/20 0.37
▸ NOS3 P29474 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ BHMT Q93088 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Carnitine SCHEMBL9128766 0.86 GSR (0.59) GSRMAPTSLC22A16ARG2NOS2
Carnitine SCHEMBL9901519 0.86 GSR (0.59) GSRMAPTSLC22A16ARG2NOS2
Levocarnitine SCHEMBL6553881 0.86 GSR (0.59) GSRMAPTSLC22A16ARG2NOS2
Carnitine SCHEMBL27486119 0.83 SLC22A16 (0.59) GSRMAPTSLC22A16ARG2NOS2
Carnitine SCHEMBL28276640 0.80 SLC22A16 (0.51) GSRMAPTSLC22A16ARG2NOS2
Lysine SCHEMBL27799649 0.78 GSR (0.83) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL27799650 0.78 GSR (0.83) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL18815986 0.78 GSR (0.91) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL27946776 0.77 GSR (0.69) GSRARG2NOS2NOS1BLM
Lysine SCHEMBL16099029 0.77 GSR (0.69) GSRARG2NOS2NOS1BLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110229584-A1 Compound for the control of herpes simplex virus using glycyrrhizic acid, lipoic acid, allantoin, and slippery elm LIFESCAPE BIOSCIENCES 2011-09-22 — — US claimed
Send feedback